3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain
2
Neoplasms
2
Multiple Myeloma
2
Breast Carcinoma In Situ
2
Adenomatous Polyposis Coli
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Monoclonal Gammopathy of Undetermined Significance
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Condylomata Acuminata
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma
1
Adenocarcinoma
1
Interventions
Surveys and Questionnaires
5
Pemetrexed
3
Paclitaxel
3
Gemcitabine
3
Docetaxel
3
Brachytherapy
3
pembrolizumab
2
Topotecan
2
Saline Solution
2
Radiotherapy
2
Radiation
2
FANG vaccine
2
Everolimus
2
Doxorubicin
2
Cisplatin
2
Carboplatin
2
CP protocol
2
temsirolimus
1
selinexor
1
osimertinib
1
niraparib
1
fosaprepitant
1
ferumoxtran-10
1
ferrous fumarate
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alovudine
1
Vitamin D
1
Uterine Artery Embolization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Neoplasms
×
Curcumin
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled